Praxis Precision Medicines (PRAX) net assets (shareholders' equity)

Net assets · fiscal 2025
$878.14M

Praxis Precision Medicines (PRAX) had net assets of $878.14M at the end of fiscal 2025 (December 31, 2025). That is 97.1% higher than the $445.45M of fiscal 2024. Figures as of 19 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$878.14M
Change on fiscal 2024
+97.1%
Growth, 5 years
+25.0% a year
Highest on record
$878.14Mfiscal 2025
Lowest on record
-$81.01Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Praxis Precision Medicines net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 25.0% a year. Across the 7 fiscal years on record (2019–2025), the highest was $878.14M in fiscal 2025 and the lowest -$81.01M in fiscal 2019.

History · 7 fiscal years

Net assets by fiscal year

Praxis Precision Medicines net assets (shareholders' equity), year by year

Praxis Precision Medicines (PRAX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$878.14M 97.1% up
2024$445.45M 539.4% up
2023$69.67M 8.5% down
2022$76.11M 69.7% down
2021$250.81M 12.7% down
2020$287.46M—
2019-$81.01M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Praxis Precision Medicines and comparable companies
CompanyNet assetsFiscal year
Oscar Health OSCR$977.65M2025
TG Therapeutics TGTX$648.02M2025
Praxis Precision Medicines PRAX$878.14M2025
Twist Bioscience TWST$888.02M2026
Protagonist Therapeutics PTGX$614.71M2025
Krystal Biotech KRYS$1.22B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PRAX

Praxis Precision Medicines, figure by figure

Praxis Precision Medicines (PRAX) overview: price, valuation and scorecardAll health care companies by market value

Praxis Precision Medicines net assets (shareholders' equity): questions and answers

What are Praxis Precision Medicines's net assets?

Praxis Precision Medicines (PRAX) had net assets of $878.14M at the end of fiscal 2025 (December 31, 2025). That is 97.1% higher than the $445.45M of fiscal 2024.

What is the growth rate of Praxis Precision Medicines's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 25.0% a year.

What are the highest and lowest net assets figures on record for Praxis Precision Medicines?

Across the 7 fiscal years on record (2019–2025), the highest was $878.14M in fiscal 2025 and the lowest -$81.01M in fiscal 2019.

How is Praxis Precision Medicines's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Praxis Precision Medicines it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Praxis Precision Medicines (PRAX) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/PRAX/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.